These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4473235)

  • 1. An animal model of depression.
    Takahashi R; Nagayama H; Kido A; Morita T
    Biol Psychiatry; 1974 Oct; 9(2):191-204. PubMed ID: 4473235
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of tetrabenazine-induced behavioural depression by imipramine on a discrete-trial avoidance escape schedule.
    Székely JI; Borsy J; Ildikó K
    Psychopharmacologia; 1974; 38(4):339-43. PubMed ID: 4427985
    [No Abstract]   [Full Text] [Related]  

  • 3. Mescaline: no tolerance to excitatory effects.
    Bridger WH; Mandel IJ; Stoff DM
    Biol Psychiatry; 1973 Oct; 7(2):129-38. PubMed ID: 4748845
    [No Abstract]   [Full Text] [Related]  

  • 4. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of imipramine hydrochloride on several models in subordinated mice.
    Saldívar-González A; Gómez-Laguna D; Olea-Wagner K; Posadas-Andrews A; Rojas JA; Mayagoitia L; Mondragón-Ceballos R
    Proc West Pharmacol Soc; 2002; 45():168-70. PubMed ID: 12434571
    [No Abstract]   [Full Text] [Related]  

  • 6. Similar action of imipramine and arginine-vasopressin in the social interaction test.
    Popik P; Vetulani J
    Pol J Pharmacol; 1993; 45(3):323-5. PubMed ID: 8220664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of age on susceptibility to the induction of depressive behavior and imipramine in rats.
    Sun MK; Alkon DL
    Behav Pharmacol; 2008 Jul; 19(4):334-8. PubMed ID: 18622181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
    Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
    Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats.
    Breuer ME; Groenink L; Oosting RS; Westenberg HG; Olivier B
    Biol Psychiatry; 2007 Apr; 61(8):990-5. PubMed ID: 17141743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioning insulin effects.
    Siegel S
    J Comp Physiol Psychol; 1975 May; 89(3):89-99. PubMed ID: 1150967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal model of depression: retention of motor depression not predictable from the threshold of reaction to the inescapable shock.
    Golda V; Petr R
    Act Nerv Super (Praha); 1987 Jun; 29(2):113-4. PubMed ID: 3661094
    [No Abstract]   [Full Text] [Related]  

  • 12. Reactivity to the electric shocks and motor depression as a consequence of inescapable shocking: the effect of chronic imipramine treatment.
    Golda V; Petr R
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1988; 31(1):61-72. PubMed ID: 3206176
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
    Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
    Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal model of depression: imipramine, bromocriptine and lisuride alleviate motor depression.
    Golda V; Petr R; Rozsíval V; Suba P
    Act Nerv Super (Praha); 1986 Mar; 28(1):26-7. PubMed ID: 3727904
    [No Abstract]   [Full Text] [Related]  

  • 15. Antidepressant effect of Chaihu-Shugan-San extract and its constituents in rat models of depression.
    Kim SH; Han J; Seog DH; Chung JY; Kim N; Hong Park Y; Lee SK
    Life Sci; 2005 Jan; 76(11):1297-306. PubMed ID: 15642599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity.
    D'Aquila PS; Panin F; Castelli MP; Serra G
    Behav Pharmacol; 2006 Mar; 17(2):101-6. PubMed ID: 16495718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lithium pretreatment on amphetamine and DMI tetrabenazine produced psychomotor behavior.
    D'Encarnacao PS; Anderson K
    Dis Nerv Syst; 1970 Jul; 31(7):494-6. PubMed ID: 5505579
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
    Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
    Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
    Pałucha A; Brański P; Szewczyk B; Wierońska JM; Kłak K; Pilc A
    Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antidepressant-like action of stereoisomers of imidobenzenesulfonylaziridines in mice evaluated in the forced swimming test.
    Duarte FS; Andrade Eda S; Vieira RA; Uieara M; Nunes RJ; de Lima TC
    Bioorg Med Chem; 2006 Aug; 14(15):5397-401. PubMed ID: 16698270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.